For the second time in 2 years, our lawmakers have created federal taxcuts designed to spur business investment. However, despite record-low interestrates, affording the funds to acquire the property and equipment to takeadvantage of those tax cuts has never been harder. Into the breach has steppedthe U.S. Small Business Administration (SBA).
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.